Amirhosein Mortezaei

Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial

S. Akhondzadeh, M. Shalbafan, Leila Kamalzadeh, 2020, Journal of clinical pharmacy and therapeutics.

Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control

S. Akhondzadeh, B. Daraei, A. Jamshidi, 2020 .

Application of saffron as a neuroprotective agent

S. Akhondzadeh, Erfan Sahebolzamani, S. Mortazavi, 2020 .

L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial.

S. Akhondzadeh, M. Shalbafan, M. E. Ardebili, 2020, Journal of affective disorders.

Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.

M. Mohammadi, S. Akhondzadeh, E. Khadem, 2019, Journal of child and adolescent psychopharmacology.

5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control

S. Akhondzadeh, S. B. Mousavi, R. Alikhani, 2020, International clinical psychopharmacology.

Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: A double‐blind randomized trial with placebo control

S. Akhondzadeh, Erfan Sahebolzamani, Ali Aqamolaei, 2018, Psychiatry and clinical neurosciences.